DOMINANT CYTOTOXIC NK CELL SUBSET WITHIN CLPD-NK PATIENTS IDENTIFIES A MORE AGGRESSIVE NK CELL PROLIFERATION

EHA Library, Gregorio Barilà, 215689

IMMUNOPROFILING OF HIV-ASSOCIATED LYMPHADENOPATHY: HIGH-THROUGHPUT ANALYSIS OF THE T CELL RECEPTOR GENE REPERTOIRE SUPPORTS EPITOPE-SPECIFIC T CELL RESPONSES

EHA Library, Evangelia Stalika, 215690

SUPERIORITY OF AVATROMBOPAG TO PLACEBO IN I REDUCING PLATELET TRANSFUSIONS IN PATIENTS WITH THROMBOCYTOPENIA AND CHRONIC LIVER DISEASE UNDERGOING SCHEDULED PROCEDURES- POOLED ANALYSIS OF 2 STUDIES

EHA Library, Kavita Aggarwal, 215691

PREDICTIVE FACTORS FOR DEVELOPING SYSTEMIC LUPUS ERYTHEMATOSUS AFTER CHILDHOOD AUTOIMMUNE CYTOPENIA

EHA Library, Nathalie Aladjidi, 215693

THE POLYMORPHISM OF CASPASE RECRUITMENT DOMAIN-CONTAINING PROTEIN 9 GENE MAY CONTRIBUTE TO RISK OF IMMUNE THROMBOCYTOPENIA

EHA Library, Zi Sheng, 215694

FEATURES OF PRN1008, A BRUTON’S TYROSINE KINASE INHIBITOR, IN CLINICAL DEVELOPMENT FOR IMMUNE THROMBOCYTOPENIC PURPURA

EHA Library, Steven Gourlay, 215695

ATRA CORRECTS IMPAIRED MACROPHAGE FUNCTION IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA THROUGH A20/NLRP3 SIGNALING PATHWAY

EHA Library, Yun He, 215696

RH-TPO RESTORES MEGAKARYOCYTES AND BONE MARROW NICHE COMPONENTS IN THE TREATMENT OF SEVERE THROMBOCYTOPENIA IN PATIENTS WITH CIRRHOSIS ASSOCIATED WITH HEPATITIS B

EHA Library, Wan-Yi Zhai, 215697

A HIGH-THROUGHPUT SCREENING ASSAY TO EVALUATE CHEMOTHERAPY-INDUCED MYELOSUPPRESSION USING HEALTHY PERIPHERAL BLOOD AND BONE MARROW

EHA Library, Dimitrios Tsallos, 215698

A NOVEL ACQUIRED RUNX1 VARIANT IS RESPONSIBLE FOR ANKRD26 DYSREGULATION AND THROMBOCYTOPENIA IN SPORADIC FORM OF MYELODYSPLASTIC SYNDROME

EHA Library, Fabrizio Vianello, 215699

FACTORS AFFECTING THROMBOPOIETIN RECEPTOR AGONIST REINITIATION AFTER DISCONTINUATION IN WELL-CONTROLLED PATIENTS WITH IMMUNE THROMBOCYTOPENIA IN THE UK: RESULTS FROM A MODIFIED DELPHI CONSENSUS PANEL

EHA Library, Anuja Roy, 215700

IMMATURE PLATELET FRACTION (IPF): AN INTERESTING TOOL TO INVESTIGATE THROMBOCYTOPENIA

EHA Library, Zoe Van de Wyngaert, 215701

INTERLEUKIN-1 RECEPTOR ANTAGONIST GENE POLYMORPHISM IN EGYPTIAN CHILDREN AND ADOLESCENTS WITH IMMUNE THROMBOCYTOPENIA: ASSOCIATION WITH DISEASE SUSCEPTIBILITY, RESPONSE TO THERAPY AND OUTCOME

EHA Library, Mohammed Mostafa Kamel Al-tawil, 215702

CLINICAL CHARACTERISTICS AND TREATMENT COURSES FOR CYTOMEGALOVIRUS-ASSOCIATED THROMBOCYTOPENIA IN IMMUNOCOMPETENT CHILDREN AFTER NEONATAL PERIOD

EHA Library, Ye Ji Sim, 215703

RAISED EXPRESSION OF APRIL IN THE PLATELET WITH IMMUNE THROMBOCYTOPENIA AND ITS CLINICAL IMPLICATIONS

EHA Library, Yunfeng Hao, 215704

EVALUATION OF HIT SYNDROME WITH AN AUTOMATED IMMUNOASSAY IN CORRELATION WITH THE 4T SCORE IN CARDIOVASCULAR PATIENTS

EHA Library, Theoni Kanellopoulou, 215705

IMMATURE PLATELET FRACTION AS A MARKER OF THROMBOPOIESIS IN THROMBOCYTOPENIC PATIENTS

EHA Library, David J Camilleri, 215706

CHANGES IN PLATELET AGGREGATION DURING PREGNANCY AND THE IMMEDIATE POSTPARTUM PERIOD

EHA Library, Brwa Hussein, 215707

CHANGING PROFILE OF PLATELET ACTIVITY AND TURNOVER INDICES DURING TREATMENT RESPONSE OF IMMUNE THROMBOCYTOPENIA: PREDICATIVE VALUE OF REPONSE BY GLYCOCALICIN AND SOLUBLE CD40 LIGAND

EHA Library, Hung Chang, 215708

THE IMPACT OF HIGH MOBILITY GROUP BOX 1 IN THE PATHOGENESIS OF IMMUNE THROMBOCYTOPENIA

EHA Library, Mehmet Baysal, 215709

WHAT ARE THE UNDERLYING CAUSES AND CLINICAL CHARACTERISTICS OF CHILDREN WITH REACTIVE THROMBOCYTOSIS AT A KOREAN TERTIARY MEDICAL CENTER?

EHA Library, Ye Ji Sim, 215710

STUDIES ON PLATELET FUNCTION IN A GROUP OF CLL PATIENTS DURING THE FIRST YEAR OF IBRUTINIB TREATMENT

EHA Library, Bozena Sokolowska, 215712

VALIDATION OF THE PLASMIC SCORE FOR THROMBOTIC MICROANGIOPATIES IN A SINGLE UNVERSITY HOSPITAL

EHA Library, Maria del Carmen Ballester Ruiz, 215713

OCCURRENCE AND MANAGEMENT OF HEPATOBILIARY ADVERSE EVENTS (AES) IN ADULTS WITH IMMUNE THROMBOCYTOPENIA (ITP) DURING LONG-TERM TREATMENT WITH ELTROMBOPAG: RESULTS FROM THE EXTEND STUDY

EHA Library, Abderrahim Khelif, 215714

BENEFIT OF EARLY TREATMENT WITH BLINATUMOMAB: LONG-TERM SURVIVAL OUTCOMES FOR ADULT PATIENTS WITH RELAPSED/REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA RECEIVING FIRST VS SUBSEQUENT SALVAGE THERAPY

EHA Library, Franziska Severin, 215715

HEALTH-RELATED QUALITY OF LIFE AND RATES OF EMERGENCY ROOM VISITS AND HOSPITALIZATION IN PATIENTS WITH AL AMYLOIDOSIS: A PROSPECTIVE ANALYSIS

EHA Library, Tiffany Quock, 215716

COST COMPARISON OF TREATMENT STRATEGIES FOLLOWING INITIATION WITH RD VERSUS VMP PLUS DARATUMUMAB IN NEWLY DIAGNOSED PATIENTS INELIGIBLE FOR ASCT

EHA Library, Graham Jackson, 215717

IMPROVABLE LIFESTYLE FACTORS IN LYMPHOMA SURVIVORS

EHA Library, Carla Minoia, 215718

QUALITY OF LIFE IN ADVANCED-STAGE,ASYMPTOMATIC,NON-BULKY FOLLICULAR LYMPHOMA TREATED WITH RITUXIMAB SHOWS SIGNIFICANT IMPROVEMENT COMPARED WITH WATCHFUL-WAITING: PHASE 3 RANDOMISED INTERNATIONAL STUDY

EHA Library, Maria A V Marzolini, 215719

HOW TO IDENTIFY PATIENTS WITH MALIGNANT HEMOPATHIES WHO DON’T BENEFIT FROM STANDARD DOSE CHEMOTHERAPY

EHA Library, Stéphanie Dubruille, 215720

THE ROLE OF MENTAL AND BEHAVIORAL DISORDERS IN LEUKEMIA PREDISPOSITION: A NATIONWIDE CASE-CONTROL STUDY

EHA Library, Hanna Moisander-Joyce, 215721

IMPACT OF CMV PROPHYLAXIS ON RATES OF REHOSPITALIZATION IN ADULT CMV SEROPOSITIVE ALLOGENEIC HSCT RECIPIENT: EXPERIENCE FROM THE LETERMOVIR PHASE 3 CLINICAL TRIAL

EHA Library, Jonathan SCHELFHOUT, 215722

QUALITY OF LIFE IN PATIENTS WITH RARE HEREDITARY HEMOLYTIC ANEMIA, THE IMPORTANCE OF SOCIAL SUPPORT

EHA Library, Stephanie van Straaten, 215723

HOW PHYSICIANS' AND PATIENTS' CHARACTERISTICS AFFECT THE LENGTH OF PATIENTS' VISIT IN THE HEMATO-ONCOLOGICAL CLINIC.

EHA Library, IRINA AMITAI, 215724

SYSTEMATIC REVIEWS OF ECONOMIC BURDEN AND HEALTH-RELATED QUALITY OF LIFE (HRQOL) IN PATIENTS WITH ACUTE MYELOID LEUKAEMIA (AML)

EHA Library, Rachel Bosshard, 215725

VENETOCLAX IMPROVES QUALITY OF LIFE FOR PATIENTS WITH RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Tara Cochrane, 215726

NO ASSOCIATION BETWEEN INDOOR RADON AND CHILDHOOD LEUKEMIA IN FRECCLE (FINNISH REGISTER-BASED CASE-CONTROL STUDY OF CHILDHOOD LEUKEMIA)

EHA Library, Atte Nikkilä, 215727

CLARITHROMYCIN ADDED TO THE VCD REGIMEN CAUSES REDUCED HEALTH-RELATED QUALITY OF LIFE IN MULTIPLE MYELOMA PATIENTS

EHA Library, Lene Kongsgaard Nielsen, 215728

RELINF PROJECT: PROSPECTIVE EPIDEMIOLOGICAL REGISTRY OF LYMPHOID NEOPLASMS IN SPAIN, ON BEHALF OF GELTAMO GROUP

EHA Library, Mariana Bastos Oreiro, 215729

A HEALTH STATE UTILITY MODEL ESTIMATING THE IMPACT OF IVOSIDENIB ON QUALITY OF LIFE IN PATIENTS WITH RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA

EHA Library, Michael Storm, 215730

ASSESSMENT OF ADHERENCE IN HAEMOPHILIA PATIENTS - EVALUATION OF AN US INSTRUMENT AND DEVELOPMENT OF A NEW QUESTIONNAIRE FOR USE IN GERMANY

EHA Library, Sylvia von Mackensen, 215731

HEALTH-RELATED QUALITY OF LIFE (HRQOL) IN PEDIATRIC PATIENTS WITH RED CELL PYRUVATE KINASE DEFICIENCY

EHA Library, Paraskevi Klothaki, 215732

QUALITY OF LIFE IS REDUCED IN PATIENTS WITH (SUSPECTED) PLATELET FUNCTION DISORDERS

EHA Library, Maaike Blaauwgeers, 215733

PALLIATIVE CARE INDICATION IN ONCOHEMATOLOGIC PATIENTS: A COMPARISON TO SOLID TUMOR PATIENTS

EHA Library, Lucia Morais, 215734

COST PER MEDIAN MONTH OF PROGRESSION‐FREE SURVIVAL FOR DARATUMUMAB PLUS BORTEZOMIB AND DEXAMETHASONE COMPARED WITH CARFILZOMIB PLUS DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA

EHA Library, Eric Maiese, 215735

EFFICACY AND SAFETY OF FACILITATED SUBCUTANEOUS IGG ADMINISTRATION IN PATIENTS WITH SECONDARY IMMUNODEFICIENCY DUE TO HEMATOLOGICAL MALIGNANCIES. A SINGLE-CENTER RETROSPECTIVE ANALYSIS.

EHA Library, Maria Dimou, 215736

IMPACT OF LOW GRADE ADVERSE EVENTS OF TYROSINE KINASE INHIBITORS ON THE QUALITY OF LIFE OF PATIENTS TREATED FOR CHRONIC MYELOID LEUKEMIA

EHA Library, S.M.Amine BENLAZAR, 215737

HEME-INDUCIBLE LIPID OXIDATION PATTERN SUPPORTS MONITORING OF CELL-FREE HEMOGLOBIN ACTIVITY IN PATIENTS WITH SICKLE CELL DISEASE.

EHA Library, Jeremy Deuel, 215738

COMPLEMENT ACTIVATION IN HOMOZYGOUS SICKLE CELL DISEASE PATIENTS IS MODULATED BY HYDROXYUREA

EHA Library, Lubka Roumenina, 215739

EARLY RECOGNITION OF THE SICKLING PROCESS OF ERYTHROCYTES BY LABEL-FREE LIGHT MICROSCOPIC IMAGING IN PATIENTS WITH SICKLE CELL DISEASE

EHA Library, Irene Lorand-Metze, 215741

SICKLE CELL DISEASE SEVERITY MEASURE: DEVELOPMENT, TRANSLATION, AND PATIENT CULTURAL SENSITIVITY VALIDATION

EHA Library, Kenneth Bridges, 215742

IMPROVEMENT OF THE MULTIDISCIPLINARY MANAGEMENT OF SICKLE CELL DISEASE PATIENTS: IMPLEMENTATION OF A SICKLE CELL DISEASE PATIENT’S CLINICAL DATABASE: BELGIAN REGISTER OF SICKLE CELL DISEASE PATIENTS

EHA Library, Beatrice Gulbis, 215743

VARIATIONS IN COMPLICATIONS RELATED TO VASO-OCCLUSIVE CRISES AND HYDROXYUREA USE IN PATIENTS WITH SICKLE CELL DISEASE: OBSERVATIONS FROM STUDIES IN THE USA, SPAIN AND THE GULF REGION

EHA Library, Elena Cela, 215744

CORRELATION BETWEEN HEMOLYSIS AND HYPERCOAGULABILITY MARKERS AND EFFECTS OF HYDROXYUREA THERAPY IN SICKLE CELL PATIENTS

EHA Library, Maria de Fátima Sonati, 215745

INFLUENCE OF BCL11A POLYMORPHYSMS ON FETAL HEMOGLOBIN LEVELS AND HAEMOLYSIS MARKERS IN SICKLE CELL ANEMIA PEDIATRIC PATIENTS NOT RECEIVING HYDROXYUREA

EHA Library, Dalila Luciola ZANETTE, 215746

TICAGRELOR VERSUS PLACEBO FOR THE REDUCTION OF VASO-OCCLUSIVE CRISES IN PEDIATRIC SICKLE CELL DISEASE: DESIGN OF A RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, MULTICENTER PHASE 3 STUDY (HESTIA3)

EHA Library, Matthew Heeney, 215747

NOVEL TRIAL DESIGN TO EVALUATE ORAL VOXELOTOR FOR THE TREATMENT OF SICKLE CELL DISEASE: THE PHASE 3 HEMOGLOBIN OXYGEN AFFINITY MODULATION TO INHIBIT SICKLE HEMOGLOBIN POLYMERIZATION (HOPE) TRIAL

EHA Library, Kenneth I. Ataga, 215748

OUTCOME OF PHILADELPHIA CHROMOSOME-POSITIVE ADULT ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS RECEIVING TYROSINE KINASE INHIBITOR MAINTENANCE THERAPY AFTER ALLOGENEIC STEM CELL TRANSPLANTATION

EHA Library, Tuija Tapaninen, 215749

PD-1 OVEREXPRESSION ON BONE MARROW RESIDENT CD8+ MEMORY T-CELL SUBSETS COULD BE A PREDICTABLE MARKER FOR LEUKEMIA RELAPSE AFTER ALLOGENEIC STEM CELL TRANSPLANTATION.

EHA Library, Mikhail Drokov, 215750

OUTCOME OF SECOND SOLID CANCER AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION: A COHORT STUDY ON 4065 PATIENTS ON BEHALF OF THE COMPLICATIONS AND QUALITY OF LIFE WORKING PARTY OF THE EBMT

EHA Library, André Tichelli, 215751

SIMILAR OUTCOMES OF REDUCED INTENSITY HAPLOIDENTICAL TRANSPLANTATION WHEN COMPARED TO MATCHED UNRELATED DONOR TRANSPLANT IN DIFFUSE LARGE B CELL LYMPHOMA. A JOINT ANALYSIS FROM CIBMTR-LC & EBMT-LWP.

EHA Library, Anna Sureda, 215752

TARGETING EXPANDED GUT HOMING EFFECTOR T CELL LINEAGES IN ACUTE INTESTINAL GRAFT VERSUS HOST DISEASE: IMPLICATIONS FOR VEDOLIZUMAB

EHA Library, Varun Mehra, 215753

ELTROMBOPAG TO IMPROVE PLATELET RECOVERY IN HAPLOIDENTICAL STEM CELL TRANSPLANTS (HAPLO-SCT): RESULTS OF A PHASE II TRIALPLUS A COMPARISON TO CONTROL PATIENTS

EHA Library, Uday R. Popat, 215754

ASSOCIATION OF SOCIO-ECONOMIC FACTORS WITH SURVIVAL OF PATIENTS WHO EXPERIENCE SEVERE CLASSIC ACUTE GVHD AFTER ALLO-HSCT. A RETROSPECTIVE STUDY BY THE TRANSPLANT COMPLICATIONS WORKING PARTY, EBMT

EHA Library, Andrzej Frankiewicz, 215755

COMPARISON OF REDUCED-INTENSITY CONDITIONING REGIMENS IN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA > 45 YEARS UNDERGOING ALLOGENEIC STEM CELL TRANSPLANTATION – A RETROSPECTIVE STUDY BY THE ALWP/EBMT

EHA Library, Zinaida Peric, 215756

A PHASE I/II TRIAL OF INTRAVENOUS AZACITIDINE FOR ACUTE GVHD PROPHYLAXIS IN PATIENTS UNDERGOING MATCHED UNRELATED STEM CELL TRANSPLANTATION: INTERIM PHASE II RESULTS

EHA Library, Mark Schroeder, 215757

BUSULFAN FLUDARABINE (BU-FLU) COMPARED TO THIOTEPA BUSULFAN FLUDARABINE (TBF) FOR ALLOGENEIC TRANSPLANTS IN ACUTE MYELOID LEUKEMIA (AML) OR REFRACTORY ANEMIA WITH EXCESS BLASTS (RAEB) IN REMISSION

EHA Library, Andrea Bacigalupo, 215758

EFFICACY AND SAFETY OF DEFIBROTIDE BY VENO-OCCLUSIVE DISEASE/SINUSOIDAL OBSTRUCTION SYNDROME (VOD/SOS) DIAGNOSTIC CRITERIA IN AN EXPANDED-ACCESS (T-IND) STUDY

EHA Library, Selim Corbacioglu, 215759

PLASMA PRESEPSIN LEVEL IS A PREDICTIVE MARKER OF SEVERE ACUTE GVHD AFTER ALLO-HSCT: USEFULNESS AS A BIOMARKER OF ALLO-HSCT RELATED COMPLICATION

EHA Library, Tatsuo Oyake, 215760

ROLE OF IFN-GAMMA IN IMMUNE-MEDIATED GRAFT FAILURE AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Pietro Merli, 215761

EFFECTS OF POST-AUTO-HSCT MRI BONE MARROW LESIONS ON PROGRESSION-FREE SURVIVAL IN PATIENTS WITH MM

EHA Library, Maxim Solovev, 215762

COMBINED EVALUATION OF DISEASE RISK INDEX AND ABCG2 EXPRESSION IDENTIFY AML PATIENTS AT A VERY HIGH RISK OF RELAPSE AFTER ALLOGENEIC STEM CELL TRANSPLANTATION

EHA Library, Daniela Damiani, 215763

AFTER ALLOGENEIC HEMATOPOIETIC TRANSPLANTATION, A COMPOSITE SCORE BASED ON PLASMATIC LEVELS OF IL-2 RECEPTOR AND TIM-3, CAN PREDICT, AT DAY +18, TRM AND SEVERE A-GVHD

EHA Library, Giuseppe MILONE, 215764

A NEW ULTRASONOGRAPHY-BASED SCORING SYSTEM IS EFFECTIVE DIAGNOSTIC TOOL FOR SINUSOIDAL OBSTRUCTION SYNDROME AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Mutsumi Nishida, 215765

THE SIGNIFICANCE OF PERI-TRANSPLANTATION MINIMAL RESIDUAL DISEASE ASSESSED BY MULTIPARAMETER FLOW CYTOMETRY ON OUTCOMES FOR ADULT AML PATIENTS RECEIVING HAPLOIDENTICAL ALLOGRAFTS

EHA Library, Jing Liu, 215766

CHANGES IN THE NUMBER OF BONE MARROW LESIONS AND TUMOUR MASS ON MRI IN PATIENTS WITH MM FOLLOWING AUTO-HSCT

EHA Library, Maxim Solovev, 215767

ACUTE INTESTINAL GRAFT-VERSUS-HOST DISEASE AMONG PATIENTS UNDERGOING ALLOGENEIC CELL TRANSPLANT FOR HEMATOLOGICAL MALIGNANCY IN THE UNITED STATES: A RETROSPECTIVE CLAIMS DATABASE ANALYSIS

EHA Library, Aliki Taylor, 215768

ALLOGENEIC HEMATOPOIETIC STEM CELLS TRANSPLANTATION FOR NON-HODGKIN’S LYMPHOMA IN SWITZERLAND. 30 YEARS OF EXPERIENCE 1985-2017.

EHA Library, Stavroula Masouridi-Levrat, 215769

PHASE 2, OPEN-LABEL STUDY OF DEFIBROTIDE FOR PREVENTION OF ACUTE GVHD FOLLOWING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT (HSCT)

EHA Library, Selim Corbacioglu, 215770

PROGNOSTICATION OF CHRONIC GRAFT VERSUS HOST DISEASE: THE IMPACT OF IMMUNE RECONSTITUTION.

EHA Library, Fabio Serpenti, 215771

UTILIZATION AND OUTCOMES OF FERTILITY PRESERVATION TECHNIQUES IN WOMEN UNDERGOING ALLOGENIC HEMATOPOIETIC CELL TRANSPLANT

EHA Library, Alexandra Higgins, 215772

LOW INCIDENCE OF SYMPTOMATIC OSTEONECROSIS AFTER ALLOGENEIC HSCT IN CHILDREN WITH HIGH-RISK OR RELAPSED ALL – RESULTS OF THE ALL-SCT 2003 TRIAL

EHA Library, Michaela Kuhlen, 215773

EARLY BLOOD STREAM INFECTION AFTER BMT IS ASSOCIATED WITH CYTOKINE DYSREGULATION AND POOR OVERALL SURVIVAL

EHA Library, Kate Markey, 215774

REGRESSION TREE BASED MODEL FOR PREDICTING NON-RELAPSE MORTALITY IN AML PATIENTS ALLO-TRANSPLANTED IN FIRST COMPLETE REMISSION

EHA Library, Anish Puliyayil, 215775

COMPARISON OF BUSULFAN/CYCLOPHOSPHAMIDE ALONE AND IN COMBINATION WITH THIOTEPA OR ANTI-THYMOCYTE GLOBULIN ON HEMATOPOIETIC STEM CELL TRANSPLANTATION OUTCOME AMONG BETA-THALASSEMIA PATIENTS

EHA Library, Saqib Ansari, 215776

SECOND TRANSPLANT FOR PRIMARY GRAFT FAILURE , FOLLOWING HAPLOIDENTICAL GRAFTS WITH POST-TRANSPLANT CYCLOPHOSPHAMIDE

EHA Library, SABRINA GIAMMARCO, 215777

SUBPOPULATIONS OF MONOCYTES AND B REGULATORY CELLS IN PATIENTS WITH CHRONIC GRAFT-VERSUS-HOST DISEASE

EHA Library, Drazen Pulanic, 215778

LIFESTYLE BEHAVIOR AMONG LYMPHOMA SURVIVORS AFTER HIGH DOSE THERAPY WITH AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Hanne Bersvendsen, 215779

CTLA-4 GENE POLIMORPHISM INFLUENCE THE OUTCOME OF HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Petra Kovy, 215780

ELDERLY PATIENTS WITH MULTIPLE MYELOMA: LONG-TERM OUTCOME FOLLOWING INDUCTION WITH NOVEL DRUGS AND AUTOLOGOUS STEM CELL TRANSPLANT

EHA Library, Swabirah Rassool, 215781

SEVERE PRE-ALLO-HSCT IRON OVERLOAD (IO), MEASURED BY LIVER MRI, SIGNIFICANTLY IMPAIRED THE PROCEDURE LONG-TERM OUTCOME

EHA Library, Juan Carlos Vallejo Llamas, 215782

INCIDENCE AND RISK FACTORS FOR THE DEVELOPMENT OF HEMORRHAGIC CYSTITIS ON HAPLOIDENTICAL TRANSPLANTATION

EHA Library, Cynthia ACOSTA FLEITAS, 215783

THREE MONTH FULL WHOLE BLOOD AND MIXED T CELL CHIMERISM IS ASSOCIATED WITH SUPERIOR OUTCOMES IN REDUCED-INTENSITY ALEMTUZUMAB-BASED ALLOGENEIC STEM CELL TRANSPLANTS FOR HAEMATOLOGICAL MALIGNANCIES

EHA Library, Alex Kanellopoulos, 215784

OUTCOMES OF SECOND ALLOGENEIC STEM CELL TRANSPLANTATION FOR RELAPSE OF HEMATOLOGICAL DISEASES OR GRAFT FAILURE: A SINGLE-CENTRE EXPERIENCE

EHA Library, Monica Poiani, 215785

CLOFARABINE- BASED CYTOREDUCTIVE TREATMENT FOLLOWED BY MYELOABLATIVE CONDITIONING AND ALLOGENEIC STEM CELL TRANSPLANTATION IN CHILDREN WITH HIGH-RISK, RELAPSED OR REFRACTORY HEMATOLOGIC MALIGNANCIES.

EHA Library, DIEGO MEDINA VALENCIA, 215786

SELECTIVE INHIBITION OF OXIDATIVE PHOSPHORYLATION PREVENTS LETHAL GRAFT-VERSUS-HOST DISEASE WHILE MAINTAINING ANTITUMOR IMMUNITY

EHA Library, Zachariah McIver, 215787

AN UNBALANCED MONOCYTE MACROPHAGE POLARIZATION IN THE BONE MARROW MICROENVIRONMENT MAY CAUSE THE OCCURRENCE OF POOR GRAFT FUNCTION AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Hong-Yan Zhao, 215788

COMPLEMENT-RELATED GENETIC VARIANTS IN ADULT ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS WITH TRANSPLANT-ASSOCIATED THROMBOTIC MICROANGIOPATHY

EHA Library, Eleni Gavriilaki, 215789

MURINE MODELS FOR ESTABLISHING STEROID REFRACTORY GVHD

EHA Library, Tomomi Toubai, 215790

LOW-DOSE INTERLEUKIN-2 RESTORING HUMAN REGULATORY T CELL FUNCTION IN VITRO AS A POTENTIAL APPLICATION FOR GVHD THERAPY AFTER TRANSPLANTATION

EHA Library, Tzeon-Jye Chiou, 215791